FG
RSKD icon

Formula Growth’s Riskified RSKD Stock Holding History

Formula Growth’s Portfolio RSKD Stock Details RSKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200,000
Closed -$936K – 138
2023
Q4 		$936K Buy
200,000
+50,000
+33% +$205K 0.3% 108
2023
Q3 		$672K Buy
+150,000
New +$691K 0.23% 114

Other funds holding RSKD

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
ER
EVR Research Richmond, Virginia $250M AUM 41.5% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
TP
Toronado Partners San Francisco, California $53M AUM 13.38% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return

Formula Growth's RSKD Position: Q1 2024 in Review

Formula Growth sold out of Riskified (RSKD) in Q1 2024, closing a stake of 200,000 shares — an estimated $936K sold.

Formula Growth first reported a position in RSKD in Q3 2023 and held it in 2 quarters. The position peaked at $936K in Q4 2023. 93 funds tracked by Wall St. Rank hold RSKD as of Q1 2024.

  • Formula Growth reported no remaining Riskified position as of Q1 2024 after selling out during the quarter.
  • Formula Growth sold 200,000 Riskified shares in Q1 2024, an estimated $936K.
  • Formula Growth first reported a position in Riskified in Q3 2023 and held it in 2 quarters.
  • Formula Growth's Riskified position peaked at $936K in Q4 2023.
  • 93 funds tracked by Wall St. Rank held Riskified as of Q1 2024.

Based on Formula Growth's 13F filing for Q1 2024, filed 14 May 2024.